search Result

Indian pharmaceutical industry to expand by 9%; surpass $70 billion by FY27

Between FY13 and FY18, Indian pharma companies faced severe regulatory challenges that adversely impacted their operations and ability to launch new products in regulated markets. Read more

Increased scrutiny by US FDA: A boon or bane Indian pharmaceutical sector

Even with the surge in USFDA-approved manufacturing sites in India, the proportion of Official Action Initiated (OAI) observations by the USFDA has stayed consistent at 10% of total inspections in CY23. Read more

PV sale volumes to grow 3%-5% in FY25; CareEdge

The industry is expected to exhibit moderate volume growth on account of a high base effect of FY24, shrinking order book and expectation of persistently subdued demand for entry-level variants in FY25. Read more

MSMEs: The Fight for Financing

As India seeks to become the world’s third-largest economy by 2027, measures are afoot to resolve the funding-related challenges routinely faced by the country’s humongous MSME segment to truly transform it into a strong industrial economy backbone, says Manish Pant.Read more

Roadmap to meet India’s $2 trillion export target by 2030: CareEdge Ratings

The note points out that trade will play a crucial role in enhancing the welfare of any economy through growth and productive employment opportunities.Read more

Hi There!

Now get regular updates from IPF Magazine on WhatsApp!

Click on link below, message us with a simple hi, and SAVE our number

You will have subscribed to our Industrial News on Whatsapp! Enjoy

+91 84228 74016

Reach out to us

Call us at +91 8108603000 or

Schedule a Call Back